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Background and aims: In Belgium, rotavirus (RV) vaccination is recommended since October 
2006 and reimbursed since November 2006. This study evaluated the RV genotype-specific 
vaccine effectiveness (VE), and the genotype distribution over 2.5 RV seasons (February 2008 
to June 2010) in Belgium. 
 
Methods: Sequencing methods were used to determine the genotype of RV strains in both 
vaccinated (n= 70) and unvaccinated (n= 89) children, isolated in 39 Belgian hospitals. 
Confirmed cases were children age-eligible to be vaccinated against RV (≥14 weeks of age and 
born after 1-October-2006) and hospitalized with PCR-confirmed RVGE. 
 
Results: The VE against RVGE caused by homotypic G1P[8] RV strains in children receiving a 
Rotarix™ full series vaccination compared to unvaccinated children was found to be 95% 
[95%CI 77-99%]. Against RVGE caused by heterotypic G2P[4] RV strains, the VE was found to 
be 85% [95%CI 64-94%]. G4P[8]-specific VE was 90% [95%CI 19-99%]; and G3P[8]-specific 
VE was 87% [95%CI -5-98%]. Comparison between the genotype distribution among 
vaccinated and unvaccinated children revealed that less G1P[8] RV strains were isolated in 
vaccinated children than in unvaccinated children (11/70 vs. 29/89), whereas more G2P[4] RV 
strains were isolated from vaccinated children (46/70 vs. 34/89).  
 
Conclusions: Subtle differences in VE against G1P[8] and G2P[4] RV strains in addition to 
natural seasonal fluctuations of strains could explain the higher proportion of G2P[4] strains in 
the remaining RVGE cases in Belgium. RV vaccination proved highly effective for the prevention 
of RVGE hospitalizations caused by different RV genotypes, including heterotypic G2P[4]. 
 
 
